BNET Industries
Market Cap:$12.8M
Last Fiscal Year Sales:$45.6M
- Public
- US
Dow Jones Description
Misonix designs and manufactures technology for controlling and eliminating hazardous fumes, noxious odors and powders used in forensic analysis. Whether it's fingerprinting, evidence drying or DNA testing, we have a solution for you. Our products are made in the USA at our headquarters in New York. The Misonix name is synonymous with forensic innovation. Since developing the first Evidence Drying Cabinet in 1995, we have been the leaders in protection of both forensic lab workers and the evidence they work with. Our Evidence Drying Cabinets have become a standard item for law enforcement departments throughout the country. Our newest creation is the Cyanoacrylate Fuming Chamber which automates the fingerprinting process and makes the crime lab a safer place to work. Check out our full product offering to see how we can help meet your laboratory's needs.
Number of Employees 235
Peer Companies
NAICS Code : 339111
Recent Events
-
Misonix inks Argentina distribution deal
-
Misonix Posts Q1 Loss - Quick Facts
-
Misonix Announces New Distribution Agreement For The United Arab Emirates UAE
-
Market Report -- In Play MSON
-
Misonix signs distribution agreement with WeightJust for SonaStarTM Ultrasonic Surgical Aspirator
-
Misonix Announces New Distribution Agreement for United Kingdom and Republic of Ireland
-
Misonix Reports Fourth Quarter and Fiscal Year 2009 Financial Results
-
Misonix Announces New Sales Agency Agreement for Middle East, India and Pakistan
-
Misonix Announces the Sale of Its Labcaire Business for up to $5.6 Million
News & Analysis
Filter by
misonix inc. - All News and Analysis
Misonex, Inc. F4Q08 (Qtr End 06/30/08) Earnings Call Transcript
Question-and-Answer SessionOperator Operator Instructions Your first question comes from Steve Jones – Aspen Capital. Steve Jones – Aspen Capital I guess like all of your other shareholders, we're wondering when you're going to make some money. I realize you don't give guidance but you're now trading at a 12...
Misonix Schedules Fourth Quarter and Fiscal Year 2008 Financial Results Conference Call; September 24, 2008 at 4:30 P.M. Eastern
FARMINGDALE, N.Y. -- Misonix, Inc. (NASDAQ: MSON), a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, today announced plans to release fourth quarter and fiscal year 2008 financial results on Wednesday afternoon, September...
Misonix Schedules Third Quarter Fiscal Year 2008 Financial Results Conference Call; May 9, 2008 at 11:00 A.M. Eastern
FARMINGDALE, N.Y. -- Misonix, Inc. (Nasdaq: MSON), a developer of minimally invasive ultrasonic medical device technology for the ablation of cancer and other chronic health conditions, today announced plans to release third quarter fiscal year 2008 financial results on Thursday afternoon, May 8, 2008. Michael A. McManus, President and Chief...
Misonix to Present at the Jesup & Lamont Emerging Growth Stock Conference
FARMINGDALE, N.Y. -- Misonix, Inc. (Nasdaq: MSON), a developer of therapeutic ultrasonic medical device technology for the treatment of cancer and other acute or chronic health conditions, today announced that its management will present at the Jesup & Lamont Emerging Growth Stock Conference on Thursday, February 28, 2008, which will...
Misonix to Conduct Second Quarter Fiscal Year 2008 Financial Results Conference Call and Web Cast
FARMINGDALE, N.Y. -- Misonix, Inc. (Nasdaq: MSON), a developer of minimally invasive ultrasonic medical device technology for the ablation of cancer and other chronic health conditions, invites the public to participate in a conference call and Web cast to discuss the Company's second quarter fiscal year 2008 financial results. The...
New York Times Front Page Story Features HIFU Prostate Cancer Treatment with Sonablate 500 from Misonix
FARMINGDALE, N.Y. -- Misonix, Inc. (Nasdaq: MSON), a developer of minimally invasive ultrasonic medical device technology for the treatment of cancer and other chronic health conditions, today reported that the January 18, 2008 issue of The New York Times contained a cover story featuring the use of high intensity focused...
Misonix to Conduct First Quarter Fiscal Year 2008 Financial Results Conference Call and Web Cast
FARMINGDALE, N.Y. -- Misonix, Inc. (Nasdaq: MSON), a developer of ultrasonic medical device technology for the treatment of cancer and other chronic health conditions, invites the public to participate in a conference call and Web cast to discuss the Company's first quarter fiscal year 2008 financial results. The events will...
Misonix to Conduct Fourth Quarter and Fiscal Year 2007 Financial Results Conference Call and Web Cast
FARMINGDALE, N.Y. -- Misonix, Inc. (Nasdaq: MSON), a developer of ultrasonic medical device technology for the treatment of cancer and other chronic health conditions, invites the public to participate in a conference call and Web cast to discuss the Company's fourth quarter and fiscal year 2007 financial results. The events...
Misonix to Present at the SMH Capital Investor Growth Conference
FARMINGDALE, N.Y. -- Misonix, Inc. (Nasdaq: MSON), a developer of ultrasonic medical device technology for the treatment of cancer and other chronic health conditions, today announced that it has been invited to present at the SMH Capital formerly known as Sanders Morris Harris Investor Growth Conference. The conference is being...
Misonix to Conduct Third Quarter Fiscal Year 2007 Financial Results Conference Call and Web Cast
FARMINGDALE, N.Y. -- Misonix, Inc. (Nasdaq: MSON), a developer of ultrasonic medical device technology for the treatment of cancer and other chronic health conditions, invites the public to participate in a conference call and Web cast to discuss the Company's third quarter fiscal year 2007 financial results. The event will...
- 1
- 2
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Michael A. McManus | CEO |
| Richard Zaremba | Senior Vice President & Cfo |
| Michael C Ryan | Senior Vice President, Medical Division |
| W. Paul Constantine | Senior Vice President, Strategic Planning and New Product Development |
| Dan Voic | Vice President, Res & Engineering |
| Frank Napoli | Vice President of Operations |
| Ronald Manna | Vice President Regulatory Affairs |
| T. Guy Minetti | Managing Director |
| Guy T Minetti | Founder |
| E. Y. Denard | Director, Sales, Americas |
| Lawrence Santi | Director of the Podiatric Residency Program, New York Community Hospital of Brooklyn |
| Grant Thornton | Professional Services |
| John W. Gildea | Executive |
| Karen Fine | |
| Mark Emberton | Surgeon |
| Howard Alliger | Director |
| Thomas F. O'Neill | Director |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Dr Raphael P Davis | Chairman of Neurosurgery, Ny Spine and Brain Surgery |
| Charles Miner | Board of Directors |
| Thomas F. O. Neill | Board of Directors |
Michael McManus, Jr. became President and Chief Executive Officer of the Company in November 1999. From November 1991 to March 1999, Mr. McManus was President and Chief Executive Officer of New York Bancorp, Inc. Prior to New York Bancorp, Inc., Mr. McManus held senior positions with Jamcor Pharmaceutical, Inc., Pfizer, Inc. and Revlon Corp. Mr. McManus also spent several years as an Assistant to President Reagan. Mr. McManus serves on the Board of Directors of the following publicly traded companies: American Home Mortgage Holdings, Inc.; Liquid Audio, Inc.; Novavax, Inc.; and NWH, Inc. Mr. McManus holds a B.A. degree in Economics from the University of Notre Dame and a Juris Doctorate from Georgetown University Law Center.
| Organization | Position | Status |
|---|---|---|
| Misonix Inc. | CEO | Current |
| Misonix Inc. | President | Current |
| The Ken Unangst Team | Current | |
| Novavax, Inc. | Chairman | Current |
| American Home Mortgage Investment Corp. | Board of Directors | Current |
| US2 LLC | Board of Directors | Current |
| Misonix Inc. | Board of Directors | Current |
| Home Federal Savings Bank | Chief Executive Officer | Former |
| Home Federal Savings Bank | President | Former |
| Pfizer Inc. | Vice President of Strategic Planning | Former |
| Pfizer Inc. | Corporate Counsel | Former |
| Revlon, Inc. | Former | |
| Lq Corp, Inc. | Former | |
| NWH, Inc. | Board of Directors | Current |
| Home Federal Savings Bank | Director | Former |
| Georgetown University | Juris Doctorate | Former |
| Georgetown University Law Center | Juris Doctorate | Former |
| University of Notre Dame | B.A. degree in Economics | Former |
Richard Zaremba became Vice President and Chief Financial Officer in February 1999. From March 1995 to February 1999, he was the Vice President and Chief Financial Officer of Converse Information Systems, Inc., a manufacturer of digital voice recording systems. Previously, Mr. Zaremba was Vice President and Chief Financial Officer of Miltope Group, Inc., a manufacturer of electronic equipment. Mr. Zaremba is a licensed certified public accountant in the state of New York and holds BBA and MBA degrees in Accounting from Hofstra University.
| Organization | Position | Status |
|---|---|---|
| Misonix Inc. | Senior Vice President & Cfo | Current |
| Miltope Group, Inc. | Chief Financial Officer | Former |
| Miltope Group, Inc. | Vice President | Former |
| Hofstra University | MBA Degrees In Accounting | Former |
| Hofstra University | Bba | Former |
Michael C. Ryan became Senior Vice President, Medical Division in October 2007. Prior thereto, he served as Senior Vice President and General Manager for Nomos Radiation Oncology, a manufacturer of radiological products, from 2006 to October 2007. From 1992 to 2005, Mr. Ryan was Executive Vice President, Business Development for Inter V. Mr. Ryan holds a Bachelor of Arts from John F. Kennedy College.
| Organization | Position | Status |
|---|---|---|
| Misonix Inc. | Senior Vice President, Medical Division | Current |
Dr. W. Paul Constantine became Senior Vice President Strategic Planning and New Product Development in September 2005. Dr. Constantine's career has focused on the development and management of world-class marketing and sales programs for global medical device companies. Most recently, he was responsible for two units representing medical and related products at Henry Schein, Inc. Earlier, Dr. Constantine held product development and marketing strategy positions with leading medical products suppliers, including units of and/or entities later acquired by Aesculap-B. Braun, Boston Scientific, Medtronic, and Smith & Nephew. He graduated from Samuel Merritt College with a doctorate degree after completing undergraduate studies at Loma Linda University.
| Organization | Position | Status |
|---|---|---|
| Misonix Inc. | Senior Vice President, Strategic Planning and New Product Development | Current |
| Smith & Nephew plc | Former | |
| Henry Schein, Inc. | Former | |
| Loma Linda University | doctorate degree after completing undergraduate studies | Former |
Mr. Voic became Vice President of Research and Development and Engineering in January 2002. Prior thereto, he served as Engineering Manager and Director of Engineering with the Company. Mr. Voic has approximately 14 years experience in both medical and laboratory and scientific products development. Mr. Voic holds a M.S. degree in mechanical engineering from Polytechnic University "Traian Vuia" of Timisoara, Romania and a MS degree in applied mechanics from Polytechnic University of New York.
| Organization | Position | Status |
|---|---|---|
| Misonix Inc. | Vice President, Res & Engineering | Current |
| Polytechnic University | M.S. Degree In Mechanical Engineering | Former |
Frank Napoli joined Misonix Corporation in September of 2004 as Vice President Of Operations. Most recently, he served as Vice President of Manufacturing for Spellman High Voltage Electronics Corporation, maker of high voltage power supplies, and as Director of Manufacturing for Telephonics Corporation, a manufacturer of Military and Commercial electronic equipment. Mr. Napoli has over 26 years of diversified electronics manufacturing experience. He holds a degree in mechanical engineering from NewYork Institute of Technology in Old Westbury.
| Organization | Position | Status |
|---|---|---|
| Misonix Inc. | Vice President of Operations | Current |
| Spellman High Voltage Electronics Corporation | Vice President of Manufacturing | Former |
| Telephonics Corp. | Director of Manufacturing | Former |
| New York Institute of Technology | B.S. Degree In Mechanical Engineering | Former |
| New York & Company, Inc. | Degree In Mechanical Engineering | Former |
| New York Institute of Technology | Degree In Mechanical Engineering | Former |
Ronald Manna became Vice President of New Product Development and Regulatory Affairs of the Company in January 2002. Prior thereto, Mr. Manna served as Vice President of Research and Development and Engineering, Vice President of Operations and Director of Engineering of the Company. Mr. Manna holds a B.S. degree in mechanical engineering from Hofstra University.
| Organization | Position | Status |
|---|---|---|
| Misonix Inc. | Vice President Regulatory Affairs | Current |
| Hofstra University | B.S. Degree In Mechanical Engineering | Former |
| Organization | Position | Status |
|---|---|---|
| Senior Resource Advisors | Managing Director | Current |
| Misonix Inc. | Managing Director | Current |
| Source Companies, LLC | Managing Director | Current |
| Senior Resource Advisors | Board of Directors | Current |
| Misonix Inc. | Board of Directors | Current |
| The Surf Club of Quogue | Board of Directors | Current |
| Hudson National Golf Club | Board of Directors | Current |
| Source Companies, LLC | Board of Directors | Current |
| St. Michael's College | Former |
| Organization | Position | Status |
|---|---|---|
| Senior Resource Advisors | Managing Director | Current |
| Misonix Inc. | Founder | Current |
| Misonix Inc. | Board of Directors | Current |
| Kidder, Peabody & Co. | Managing Director | Former |
| St. Michael's College | Former |
| Organization | Position | Status |
|---|---|---|
| Misonix Inc. | Director, Sales, Americas | Current |
* Director of the Podiatric Residency Program, New York Community Hospital of Brooklyn * Chief of the Podiatry Department, New York Community Hospital of Brooklyn * Consultant at the Wound Care Center of the Kingsbrook Jewish Medical Center in Brooklyn * Senior Attending of the Diabetic Clinic at the Cumberland Neighborhood Family Care Center * President of the New York State Podiatric Medical Association from May, 2004 through June 2005 * Member of the Board of Trustees of NYSPMA. Certifications * Board Certified in Podiatric Surgery since 1986
| Organization | Position | Status |
|---|---|---|
| Misonix Inc. | Director of the Podiatric Residency Program, New York Community Hospital of Brooklyn | Current |
| Organization | Position | Status |
|---|---|---|
| Misonix Inc. | Professional Services | Current |
| Organization | Position | Status |
|---|---|---|
| Misonix Inc. | Executive | Current |
| Sterling Chemicals, Inc. | Compensation Committee Chairman | Current |
| America Service Group, Inc. | Board of Directors | Current |
| Misonix Inc. | Director | Current |
| Sterling Chemicals, Inc. | Board of Directors | Former |
| The University of North Carolina | Director | Former |
| GenTek Inc. | Director | Former |
| University of Pittsburgh | Former |
| Organization | Position | Status |
|---|---|---|
| Misonix Inc. | Current | |
| Polytechnic University | BS in EE | Former |
Senior Lecturer in Oncological Urology / Honorary Consultant Urologist Institute of Urology and Nephrology Royal Free and University College London School of Medicine University College London Clinical Director Clinical Effectiveness Unit, Royal College of Surgeons of England, London Memberships * British Association of Urological Surgeons (BAUS) * BAUS Oncology Group * British Prostate Group * European Association of Urological Surgeons (EAU) * Spanish Association of Urological Surgeons (AEU) Qualifications * BSc (Hons) 2.1 1982 Psychology * MB BS 1985 * FRCS (London) 1990 * FRCS Urology 1997 * MD, University of London 1997
| Organization | Position | Status |
|---|---|---|
| Misonix Inc. | Surgeon | Current |
* Chairman of Neurosurgery - NY Spine and Brain Surgery, P.C. at Stony Brook University Hospital * Chief of Neurosurgery-University Hospital at Stony Brook * Professor of Neurosurgery * Board Certified in Neurosurgery - 1990 * Neurosurgical Residency- Mount Sinai Medical Center * Surgical Residency- Mount Sinai Medical Center * Graduated Summa Cum Laude * Member Phi Beta Kappa
| Organization | Position | Status |
|---|---|---|
| Misonix Inc. | Chairman of Neurosurgery, Ny Spine and Brain Surgery | Current |
| Stony Brook University Hospital | Former |
Dr. Miner has practiced internal medicine for over 25 years and presently has a private practice in Darien, Connecticut. He is on staff at Stamford Hospital and Norwalk Hospital, and holds a teaching position at Columbia Presbyterian Hospital. For the past ten years, Dr.Miner has also been Medical Director at Courtland Gardens Health Center, and, from 1990 through 2004, served as Medical Director of on-line health and wellness services for Lifecare, Inc., one of the largest privately owned employee benefits organizations in the U.S. and the exclusive provider of Life Event Management Services. A graduate of the University of Cincinnati College of Medicine, Dr. Miner earlier studied molecular genetics at Columbia University and completed undergraduate work by receiving a Bachelor of Science from Lehigh University. Following medical school, Dr. Miner completed a medical internship and residency at Lennox Hill Hospital in New York City. In 1982, he was appointed as a Diplomat of the American Board of Internal Medicine.
| Organization | Position | Status |
|---|---|---|
| Courtland Gardens Health Center | Medical Director | Current |
| Norwalk Hospital | Current | |
| Columbia Presbyterian Hospital | Current | |
| Misonix Inc. | Board of Directors | Current |
| Lifecare, Inc. | Medical Director | Former |
| University of Cincinnati College of Medicine | M.D. | Former |
| Lehigh University | Bachelor of Science | Former |
| Columbia University | Molecular Genetics | Former |
Howard Alliger founded the Company's predecessor in 1955 and the Company was a sole proprietorship until 1960. The Company name then was Heat Systems-Ultrasonics. Mr. Alliger was President of the Company until 1982 and Chairman of the Board until 1996. In 1996 Mr. Alliger stepped down as Chairman and ceased to be a corporate officer. He has been awarded 23 patents and has published various papers on ultrasonic technology. For three years, ending in 1991, Mr. Alliger was the President of the Ultrasonic Industry Association. Mr. Alliger holds a B.A. degree in economics from Allegheny College and also attended Cornell University School of Engineering for four years. He has also established, and is President of, two privately held entities which are engaged in pharmaceutical research and development.
| Organization | Position | Status |
|---|---|---|
| Misonix Inc. | Director | Current |
| Ultrasonic Industry Association | President | Former |
| Misonix Inc. | President | Former |
| Cornell University | B.A. Degree In Economics | Former |
| Allegheny College | B.A. Degree In Economics | Former |
| Organization | Position | Status |
|---|---|---|
| Sandler O'Neill & Partners LP | Principal | Current |
| NASDAQ Trader | Chair | Current |
| Misonix Inc. | Director | Current |
| Misonix Inc. | Member | Current |
| Misonix Inc. | Managing Director and Co-Manager | Former |
| New York University | Former |
| Organization | Position | Status |
|---|---|---|
| Misonix Inc. | Board of Directors | Current |
Executive News
-
Misonix Announces Attendance At XIV World Congress of Neurological Surgery
-
Misonix Expands Sales Organization for Direct Sales of the SonicOne(TM) Wound Management System and the SonaStar(R) Ultrasonic Surgical Aspirator in the United States
-
Novavax Announces Appointment of Frederick W. Driscoll as Vice President, Chief Financial Officer and Treasurer
-
Novavax Announces Appointment of Frederick W. Driscoll as Vice President, Chief Financial Officer and Treasurer
-
Novavax Announces Appointment of Frederick W. Driscoll as Vice President, Chief Financial...
-
Novavax Announces Appointment of Frederick W. Driscoll as Vice President, Chief Financial Officer and Treasurer
-
Novavax Announces Appointment of Frederick W. Driscoll as Vice President, Chief Financial Officer and Treasurer
-
Misonix Receives First Award for Forensic Equipment in China
Industry Transcripts by Seeking Alpha
-
Brown Shoe Co. Inc. Q3 2009 Earnings Call Transcript
on Nov 24, 2009about BWS
-
Daktronics Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Nov 24, 2009about DAKT
-
Haynes International Inc. F4Q09 (Qtr End 09/30/09) Earnings Call Transcript
on Nov 24, 2009about HAYN
-
Valspar Corp. F4Q09 (Qtr End 30/10/09) Earnings Call Transcript
on Nov 23, 2009about VAL
-
Donaldson Company Inc. F1Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Nov 19, 2009about DCI


